BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34600240)

  • 1. Discovery of novel ID2 antagonists from pharmacophore-based virtual screening as potential therapeutics for glioma.
    Zhong G; Wang Y; Wang Q; Wu M; Liu Y; Sun S; Li Z; Hao J; Dou P; Lin B
    Bioorg Med Chem; 2021 Nov; 49():116427. PubMed ID: 34600240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new small molecule inhibitors targeting isocitrate dehydrogenase 1 (IDH1) with blood-brain barrier penetration.
    Cao H; Zhu G; Sun L; Chen G; Ma X; Luo X; Zhu J
    Eur J Med Chem; 2019 Dec; 183():111694. PubMed ID: 31561044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.
    Yenugonda V; Nomura N; Kouznetsova V; Tsigelny I; Fogal V; Nurmemmedov E; Kesari S; Babic I
    J Transl Med; 2017 Oct; 15(1):210. PubMed ID: 29047383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening.
    Zou F; Pusch S; Hua J; Ma T; Yang L; Zhu Q; Xu Y; Gu Y; von Deimling A; Zha X
    Bioorg Med Chem Lett; 2018 Feb; 28(3):388-393. PubMed ID: 29290542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    Maccallini C; Di Matteo M; Gallorini M; Montagnani M; Graziani V; Ammazzalorso A; Amoia P; De Filippis B; Di Silvestre S; Fantacuzzi M; Giampietro L; Potenza MA; Re N; Pandolfi A; Cataldi A; Amoroso R
    Eur J Med Chem; 2018 May; 152():53-64. PubMed ID: 29689474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.
    Braga C; Vaz AR; Oliveira MC; Matilde Marques M; Moreira R; Brites D; Perry MJ
    Eur J Med Chem; 2019 Jun; 172():16-25. PubMed ID: 30939350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
    Assi HH; Paran C; VanderVeen N; Savakus J; Doherty R; Petruzzella E; Hoeschele JD; Appelman H; Raptis L; Mikkelsen T; Lowenstein PR; Castro MG
    J Pharmacol Exp Ther; 2014 Jun; 349(3):458-69. PubMed ID: 24696041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
    Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
    Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening.
    Elkamhawy A; Ammar UM; Paik S; Abdellattif MH; Elsherbeny MH; Lee K; Roh EJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
    Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
    Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
    Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
    Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
    Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
    Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.
    Xu D; Zhou D; Bum-Erdene K; Bailey BJ; Sishtla K; Liu S; Wan J; Aryal UK; Lee JA; Wells CD; Fishel ML; Corson TW; Pollok KE; Meroueh SO
    ACS Chem Biol; 2020 Jun; 15(6):1424-1444. PubMed ID: 32243127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isoprenoid derivative N
    Ciaglia E; Grimaldi M; Abate M; Scrima M; Rodriquez M; Laezza C; Ranieri R; Pisanti S; Ciuffreda P; Manera C; Gazzerro P; D'Ursi AM; Bifulco M
    Br J Pharmacol; 2017 Jul; 174(14):2287-2301. PubMed ID: 28419419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
    Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL
    Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
    Chen C; Wang T; Wu F; Huang W; He G; Ouyang L; Xiang M; Peng C; Jiang Q
    Drug Des Devel Ther; 2014; 8():1195-210. PubMed ID: 25214764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors.
    Lin TE; Sung LC; Chao MW; Li M; Zheng JH; Sung TY; Hsieh JH; Yang CR; Lee HY; Cho EC; Hsu KC
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):226-235. PubMed ID: 34894949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Id2 increases chemosensitivity of glioma.
    Zhao Z; He H; Wang C; Tao B; Zhou H; Dong Y; Xiang J; Wang L; Luo C; Lu Y; Yu X
    Tumour Biol; 2015 Jun; 36(6):4189-96. PubMed ID: 25773386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.